Editas Medicine (EDIT) Misses Q1 EPS by 36c
Tweet
Share
E-mail
Get Alerts EDIT Hot Sheet
Join SI Premium – FREE
Editas Medicine (NASDAQ: EDIT) reported Q1 EPS of ($0.92), $0.36 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $4.66 million versus the consensus estimate of $786.1 thousand.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- JPMorgan Assumes Kanzhun Ltd. (BZ) at Overweight
- RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
